Back to home
EW logo

Is EW (Edwards Lifesciences Corporation) Halal or Haram?

New York Stock ExchangeHealthcareMedical - Devices$47.23B2026-04-29
EW is Halal4/4 screens passed

Edwards Lifesciences clears all AAOIFI Shariah screening criteria with exceptional compliance metrics. The company carries negligible debt, representing just 1.5% of its market capitalization, which is well below the 33% threshold. Additionally, its interest income accounts for only 2.45% of total revenue, keeping it safely under the 5% limit.

Price Chart (5D)

$83.99+0.53 (+0.64%)
2026-05-012026-04-24

EW — Last 7 Days

DateOpenHighLowCloseVolumeChange
2026-05-0184.0185.0682.5384.016.6M+0.00%
2026-04-3081.5383.6380.6583.506.6M+2.42%
2026-04-2981.9582.2880.7681.225.0M-0.89%
2026-04-2884.1384.9581.5182.285.8M-2.20%
2026-04-2783.5484.7983.2283.467.2M-0.10%
2026-04-2482.5084.7482.1284.1511.8M+2.00%
2026-04-2381.5382.0079.1979.726.2M-2.22%

Discussion

Sign in to join the discussion

Loading comments...

Shariah Screening Details for EW

Business Activity

Permissible

Edwards Lifesciences passes the business activity screen because its core operations—developing transcatheter heart valve replacement and surgical structural heart solutions—provide permissible, life-saving medical devices.

Debt / Market Cap

1.49%

Debt: $705.4MThreshold: ≤33%

Interest Income

2.45%

Interest: $148.4MThreshold: ≤5%

Cash & Securities

8.95%

Cash: $4.23BThreshold: ≤33%

About Edwards Lifesciences Corporation (EW)

Edwards Lifesciences Corporation is a global leader in medical innovations for structural heart disease and critical care monitoring. The company specializes in life-saving devices, notably its transcatheter heart valve replacement systems and the PASCAL transcatheter valve repair therapies used to treat mitral and tricuspid valve diseases.

For Muslim investors, EW currently presents an attractive Halal investment opportunity, having successfully passed all AAOIFI screening criteria. The company's operations in the medical device sector are universally considered permissible, and it comfortably passes all three financial ratio tests required for Shariah compliance.

From an Islamic finance perspective, Edwards Lifesciences boasts an incredibly clean balance sheet with a remarkably low debt-to-market cap ratio of just 1.5%. Furthermore, its cash and interest-bearing securities sit at a safe 8.9% of its market value, ensuring that its primary revenue is driven by core medical sales rather than impermissible financial engineering.

While the company exhibits strong Shariah compliance, investors should continue to monitor its interest income, which currently stands at 2.45% of total revenue. Any significant increase in cash reserves generating interest could push this figure closer to the 5% AAOIFI limit, requiring careful ongoing observation.

CEO

Bernard J. Zovighian

Employees

15,800

IPO Date

2000-03-27

Headquarters

Irvine, CA, US

EW Key Financial Statistics

Revenue

$6.07B

Net Income

$1.07B

EPS (Diluted)

$1.83

Stock Price

81.92

Beta

0.94

52-Week Range

72.3-87.89

Total Debt

$705.4M

Total Equity

$10.34B

Current Ratio

3.72

EW Financial Health & Profitability

Profit Margins

Gross Margin78.1%
Operating Margin27.0%
Net Margin17.7%

Revenue Growth (YoY)

+11.5%

Prior year: $5.44B

Net Cash

$2.23B

Cash: $2.94B — Debt: $705.4M

R&D Spending

$1.08B

% of Revenue

17.8%

Frequently Asked Questions About EW

Is EW (Edwards Lifesciences Corporation) stock halal to invest in?
Based on our AAOIFI-standard shariah screening, EW is Halal and considered permissible for Muslim investors. It passed all 4 of 4 compliance screens including business activity review, debt-to-market-cap ratio (1.49% vs ≤33% threshold), interest income ratio (2.45% vs ≤5% threshold), and cash & securities ratio (8.95% vs ≤33% threshold).
What does Edwards Lifesciences Corporation do?
Edwards Lifesciences Corporation is a global leader in medical innovations for structural heart disease and critical care monitoring. The company specializes in life-saving devices, notably its transcatheter heart valve replacement systems and the PASCAL transcatheter valve repair therapies used to treat mitral and tricuspid valve diseases. For Muslim investors, EW currently presents an attractive Halal investment opportunity, having successfully passed all AAOIFI screening criteria. The company's operations in the medical device sector are universally considered permissible, and it comfortably passes all three financial ratio tests required for Shariah compliance. From an Islamic finance perspective, Edwards Lifesciences boasts an incredibly clean balance sheet with a remarkably low debt-to-market cap ratio of just 1.5%. Furthermore, its cash and interest-bearing securities sit at a safe 8.9% of its market value, ensuring that its primary revenue is driven by core medical sales rather than impermissible financial engineering. While the company exhibits strong Shariah compliance, investors should continue to monitor its interest income, which currently stands at 2.45% of total revenue. Any significant increase in cash reserves generating interest could push this figure closer to the 5% AAOIFI limit, requiring careful ongoing observation. Edwards Lifesciences Corporation operates in the Healthcare sector under the Medical - Devices industry and is headquartered in Irvine, CA, US. The company is led by CEO Bernard J. Zovighian and employs approximately 15,800 people.
What screening criteria were used for EW?
EW was screened using AAOIFI-based shariah compliance criteria. Four tests are applied: (1) Business Activity — the company's core business must not derive primary income from haram (prohibited) activities such as alcohol, gambling, tobacco, or interest-based finance. (2) Debt-to-Market-Cap — total debt must not exceed 33% of market capitalization. (3) Interest Income — interest income must not exceed 5% of total revenue. (4) Cash & Securities — cash and interest-bearing securities must not exceed 33% of market cap. EW passed 4 of these 4 screens.
Does EW require income purification?
Although EW passes all shariah screens, it does earn $148.4M in interest income (2.45% of revenue). Many scholars recommend purifying this portion by donating the equivalent percentage of any dividends received to charity. For example, if you receive $100 in dividends, you would donate approximately $2.45 to purify the income.
When was EW last screened?
EW was last screened on 2026-04-29. Shariah compliance status can change as companies report new financial data, acquire new businesses, or shift revenue streams. We recommend checking back periodically for the most up-to-date screening results.

Disclaimer

This shariah compliance assessment for EW (Edwards Lifesciences Corporation) is provided for informational purposes only and does not constitute financial, investment, or religious advice. Screening criteria are based on widely accepted AAOIFI standards, but individual scholars may differ in their opinions. Always consult with a qualified Islamic scholar and licensed financial advisor before making investment decisions. Past screening status does not guarantee future compliance. Last screened: 2026-04-29.

Other Halal Stocks in Healthcare